Key Points
- CFO Joshua Lev sold 2,500 shares on December 4 at an average price of $5.05, trimming his stake by 10.34% to 21,667 shares, according to an SEC filing.
- electroCore reported Q earnings of ($0.40) per share (missed estimates) while revenue of $8.69M beat expectations, but the company remains unprofitable with a negative ROE (−447.87%) and net margin (−47.46%), and analysts forecast −1.49 EPS for the year.
- Shares trade near $4.82 with a 12‑month range of $4.16–$19.49 and a market cap of about $38.6M; the Wall Street consensus is a Hold rating with a $25.50 target (two Buys, one Sell).
electroCore, Inc. (NASDAQ:ECOR - Get Free Report) CFO Joshua Lev sold 2,500 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average price of $5.05, for a total transaction of $12,625.00. Following the sale, the chief financial officer directly owned 21,667 shares in the company, valued at approximately $109,418.35. The trade was a 10.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
electroCore Price Performance
Shares of NASDAQ:ECOR opened at $4.82 on Friday. electroCore, Inc. has a 12 month low of $4.16 and a 12 month high of $19.49. The firm has a market capitalization of $38.56 million, a P/E ratio of -2.82 and a beta of 0.33. The company's fifty day moving average price is $5.10 and its 200 day moving average price is $5.46.
electroCore (NASDAQ:ECOR - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.07). The firm had revenue of $8.69 million for the quarter, compared to analyst estimates of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%. On average, sell-side analysts anticipate that electroCore, Inc. will post -1.49 EPS for the current year.
Hedge Funds Weigh In On electroCore
Several large investors have recently added to or reduced their stakes in ECOR. AWM Investment Company Inc. grew its holdings in electroCore by 95.0% in the 1st quarter. AWM Investment Company Inc. now owns 318,106 shares of the company's stock valued at $2,128,000 after buying an additional 154,973 shares during the period. NewEdge Advisors LLC boosted its position in shares of electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company's stock worth $1,083,000 after acquiring an additional 145,047 shares during the last quarter. International Assets Investment Management LLC increased its position in electroCore by 65.7% during the second quarter. International Assets Investment Management LLC now owns 77,020 shares of the company's stock worth $407,000 after purchasing an additional 30,550 shares during the last quarter. Jaffetilchin Investment Partners LLC raised its stake in electroCore by 26.7% during the second quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company's stock worth $221,000 after purchasing an additional 8,800 shares during the period. Finally, Jane Street Group LLC boosted its holdings in shares of electroCore by 114.4% in the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company's stock valued at $246,000 after purchasing an additional 19,599 shares during the last quarter. 26.74% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on ECOR. Weiss Ratings reissued a "sell (d-)" rating on shares of electroCore in a report on Monday. Wall Street Zen upgraded electroCore from a "sell" rating to a "hold" rating in a research note on Saturday, November 8th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $25.50.
Check Out Our Latest Stock Report on electroCore
About electroCore
(
Get Free Report)
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
